[go: up one dir, main page]

CN111187346B - Colloidal gold test strip for detecting fipronil and its metabolites and preparation method thereof - Google Patents

Colloidal gold test strip for detecting fipronil and its metabolites and preparation method thereof Download PDF

Info

Publication number
CN111187346B
CN111187346B CN202010042620.7A CN202010042620A CN111187346B CN 111187346 B CN111187346 B CN 111187346B CN 202010042620 A CN202010042620 A CN 202010042620A CN 111187346 B CN111187346 B CN 111187346B
Authority
CN
China
Prior art keywords
solution
preparation
fipronil
colloidal gold
hapten
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202010042620.7A
Other languages
Chinese (zh)
Other versions
CN111187346A (en
Inventor
周兴华
张彩芹
张勋
张涛
肖香
王云
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiangsu University
Original Assignee
Jiangsu University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangsu University filed Critical Jiangsu University
Priority to CN202010042620.7A priority Critical patent/CN111187346B/en
Publication of CN111187346A publication Critical patent/CN111187346A/en
Application granted granted Critical
Publication of CN111187346B publication Critical patent/CN111187346B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76Albumins
    • C07K14/765Serum albumin, e.g. HSA
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/44Oxygen and nitrogen or sulfur and nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531Production of immunochemical test materials
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/577Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies; monoclonal antibodies per se are classified with their corresponding antigens
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2430/00Assays, e.g. immunoassays or enzyme assays, involving synthetic organic compounds as analytes
    • G01N2430/10Insecticides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

本发明提供一种检测氟虫腈及其代谢物的胶体金试纸条及其制备方法,包括以下步骤:半抗原制备、免疫原和包被原制备、单克隆抗体的制备、金标抗体的制备、胶体金试纸条的制备;本发明用氟虫腈偶联蛋白质的包被原在硝酸纤维素膜上制作检测线,以二抗在硝酸纤维素膜上制作质控线,将样本提取液与金标抗体孵育,插入试纸条进行检测。本发明通过制备高灵敏度和高特异性的抗氟虫腈及其代谢物的单克隆抗体,而后在基于单克隆抗体之上建立速度快、成本低、灵敏度高且能同时检测氟虫腈及其代谢物的胶体金试纸条,本发明试纸条既能同时检测氟虫腈及其代谢物又无需仪器辅助,成本低、操作简单、适宜现场样本的快速筛选。

Figure 202010042620

The invention provides a colloidal gold test strip for detecting fipronil and its metabolites and a preparation method thereof, comprising the following steps: preparation of hapten, preparation of immunogen and coating original, preparation of monoclonal antibody, preparation of gold-labeled antibody Preparation, preparation of colloidal gold test strips; the present invention uses the fipronil-coupled protein coating to make a detection line on the nitrocellulose membrane, uses the secondary antibody to make a quality control line on the nitrocellulose membrane, and extracts the sample The solution was incubated with the gold-labeled antibody, and a test strip was inserted for detection. The present invention prepares high-sensitivity and high-specificity monoclonal antibodies against fipronil and its metabolites, and then builds on the monoclonal antibodies with fast speed, low cost, high sensitivity and can simultaneously detect fipronil and its metabolites. A colloidal gold test strip for metabolites, the test strip of the invention can simultaneously detect fipronil and its metabolites without instrument assistance, has low cost, simple operation, and is suitable for rapid screening of on-site samples.

Figure 202010042620

Description

一种检测氟虫腈及其代谢物的胶体金试纸条及其制备方法Colloidal gold test strip for detecting fipronil and its metabolites and preparation method thereof

技术领域technical field

本发明属于食品安全检测技术领域,具体涉及一种同时快速检测氟虫腈及其代谢物的胶体金试纸条及其制备方法。The invention belongs to the technical field of food safety detection, and in particular relates to a colloidal gold test strip for simultaneous rapid detection of fipronil and its metabolites and a preparation method thereof.

背景技术Background technique

氟虫腈,英文名称是芬普尼(fipronil),化学名称是(RS)-5-氨基-1-(2,6-二氯-4-三氟甲苯基)-4-三氟甲基亚磺酰基砒唑-3-腈,是在20世纪八十年代开发出的一种苯基吡唑类杀虫剂,是有机磷农药的替代物之一,由于其杀菌效果好且广谱性高,广泛应用在水果、蔬菜等农作物的害虫防治、家庭和娱乐场所的寄生虫和害虫的防控。氟虫腈是通过破坏害虫的γ- 氨基丁酸(GABA)控制的氯离子通道,从而破坏其正常的神经中枢系统来控制害虫。相关研究表明氟虫腈具有慢性的神经毒性,已经被定为C类的致癌物质,氟虫腈可影响人体健康并导致结膜炎,头晕,癫痫发作,躁动,出汗等症状。氟虫腈在自然环境中通过光解,氧化,还原作用降解为更加具有毒性的氟甲腈、氟虫腈砜和氟虫腈亚砜代谢产物。氟甲腈的大鼠的 LD50仅仅是其母体本身的1/6,其对大鼠的毒性远远大于其本身。氟虫腈砜对溞类的毒性约是为其母体本身的6倍,氟虫腈亚砜的生物累积性是氟虫腈母体的5倍。我国在2009年发布的1157号公告中规定了氟虫腈只限制于玉米等部分种子包衣中使用,在国标食品中农药残留限量(GB-2763-2016)中规定了氟虫腈及其代谢物在谷物、油料和油脂、蔬菜、水果、糖料和食用菌的残留限量范围是0.02~0.1mg/kg。Fipronil, the English name is fipronil (fipronil), the chemical name is (RS)-5-amino-1-(2,6-dichloro-4-trifluoromethylphenyl)-4-trifluoromethylidene Sulfonylpyrazole-3-carbonitrile is a phenylpyrazole insecticide developed in the 1980s. It is one of the substitutes for organophosphorus pesticides. Due to its good bactericidal effect and high broad-spectrum , Widely used in the pest control of fruits, vegetables and other crops, the control of parasites and pests in homes and entertainment places. Fipronil controls pests by destroying the chloride channel controlled by γ-aminobutyric acid (GABA) in pests, thereby destroying their normal nervous system. Relevant studies have shown that fipronil has chronic neurotoxicity and has been classified as a class C carcinogen. Fipronil can affect human health and cause symptoms such as conjunctivitis, dizziness, seizures, restlessness, and sweating. Fipronil is degraded into more toxic metabolites of flupronil, fipronil sulfone and fipronil sulfoxide through photolysis, oxidation, and reduction in the natural environment. The LD 50 of fluorocarbonitrile in rats is only 1/6 of that of the parent itself, and its toxicity to rats is far greater than that of itself. The toxicity of fipronil sulfone to daphnia is about 6 times that of its parent itself, and the bioaccumulation of fipronil sulfoxide is 5 times that of fipronil parent. In my country's Announcement No. 1157 issued in 2009, it is stipulated that fipronil is only limited to the use of some seed coatings such as corn, and fipronil and its metabolism are specified in the national standard food pesticide residue limit (GB-2763-2016). The residue limit range of food in grains, oilseeds and oils, vegetables, fruits, sugar crops and edible fungi is 0.02-0.1mg/kg.

目前,氟虫腈的检测方法主要是仪器分析法,主要包括气相色谱-串联质谱联用(GC-MS),液相色谱-串联质谱联用(LC-MS/MS),高效液相色谱(HPLC),高效液相二极管阵列检测法(HPLC-DAD),这些方法虽然灵敏度和准确度高,但是需要昂贵的仪器、专业操作人员、前处理复杂且耗时,因此,不适宜现场大量样本的快速筛选。免疫分析方法是基于抗原抗体的特异性反应的一种的检测方式。目前国内已授权或公告的关于氟虫腈的免疫分析检测法主要有:公开号为CN201710990416.6的一种检测氟虫腈的试剂盒及其制备方法和应用、公开号为CN201711059643.3的一种检测茶叶中氟虫腈的化学发光免疫检测试剂盒,以上两种发明均是ELISA试剂盒的发明应用,检测过程需反复洗板且耗时长,结果因操作人员不同会有一定的差异性,结果需仪器进行读数,不适宜现场大量样本的快速筛选;公开号为CN201810005898.X的一种快速检测微量氟虫睛的表面增强拉曼金标试纸条及其制备方法,该发明的检测方法拉曼信号不稳定易出现假阳现象,检测结果需借助拉曼仪器的辅助,拉曼仪器昂贵,检测成本高;公开号为2018103135712.0的一种利用光照和表面增强拉曼快速检测氟虫腈的方法,该发明的方法是通过检测氟虫腈的主要光解产物氟甲腈来间接的检测氟虫腈的存在,增加了检测步骤和时间,结果准确度不高,拉曼仪器昂贵,成本升高;公开号为 201810005478.1的一种快速检测微量氟虫腈的胶体金标试纸条及其制备方法,该发明的检测方法只针对氟虫腈本身,对更加具有毒性的氟虫腈代谢物的检测并没有涉及。氟虫腈在自然环境中极易被降解,该方法的准确度不高。At present, the detection methods of fipronil are mainly instrumental analysis methods, mainly including gas chromatography-tandem mass spectrometry (GC-MS), liquid chromatography-tandem mass spectrometry (LC-MS/MS), high performance liquid chromatography ( HPLC), high-performance liquid phase diode array detection (HPLC-DAD), although these methods have high sensitivity and accuracy, they require expensive instruments, professional operators, complicated and time-consuming pre-treatment, therefore, they are not suitable for the detection of a large number of samples on site. Quick filter. The immunoassay method is a detection method based on the specific reaction of antigen and antibody. At present, the immunoassay and detection methods for fipronil that have been authorized or announced in China mainly include: a kit for detecting fipronil with a publication number of CN201710990416.6 and its preparation method and application, a publication number of CN201711059643.3 A chemiluminescent immunoassay kit for detecting fipronil in tea. The above two inventions are both inventions and applications of ELISA kits. The detection process needs to be washed repeatedly and takes a long time. The results will vary due to different operators. The result requires an instrument for reading, which is not suitable for rapid screening of a large number of samples on site; the publication number is CN201810005898.X, a surface-enhanced Raman gold standard test strip for rapid detection of trace amounts of fipronil and its preparation method, the detection method of the invention The Raman signal is unstable and prone to false positives, and the detection results need the assistance of Raman instruments, which are expensive and costly; the publication number is 2018103135712.0, which uses light and surface-enhanced Raman to quickly detect fipronil Method, the method of this invention is to indirectly detect the existence of fipronil by detecting the main photolysis product of fipronil, flupronil, which increases the detection steps and time, the accuracy of the result is not high, the Raman instrument is expensive, and the cost rises. Gao; Publication No. 201810005478.1 A colloidal gold standard test strip for rapid detection of trace amounts of fipronil and its preparation method. The detection method of the invention is only for fipronil itself, and for the more toxic fipronil metabolites Testing is not involved. Fipronil is easily degraded in the natural environment, and the accuracy of this method is not high.

发明内容Contents of the invention

针对上述问题,本发明提供一种同时快速检测氟虫腈及其代谢物的胶体金试纸条及其制备方法,通过制备高灵敏度和高特异性的抗氟虫腈及其代谢物的单克隆抗体,而后在基于抗体之上建立速度快、成本低、灵敏度高且能同时检测氟虫腈及其代谢物胶体金试纸条,所述试纸条既能同时检测氟虫腈及其代谢物又无需仪器辅助,成本低、操作简单、适宜现场样本的快速筛选。In view of the above problems, the present invention provides a colloidal gold test strip and a preparation method thereof for rapid detection of fipronil and its metabolites at the same time. Antibodies, and then based on antibodies, the establishment of fast, low cost, high sensitivity and can simultaneously detect fipronil and its metabolites colloidal gold test strips, the test strips can simultaneously detect fipronil and its metabolites It does not require instrument assistance, is low in cost, simple in operation, and is suitable for rapid screening of on-site samples.

一种检测氟虫腈及其代谢物的胶体金试纸条制备方法,包括以下步骤:A method for preparing a colloidal gold test strip for detecting fipronil and its metabolites, comprising the following steps:

半抗原的制备:将氟虫腈通过酸水解法并加入乙酸,引入羧基,制备得到半抗原;Preparation of hapten: fipronil is hydrolyzed by acid and acetic acid is added to introduce carboxyl group to prepare hapten;

免疫原和包被原的制备:将所述半抗原通过活化酯法偶联蛋白质分别制备免疫原和包被原;Preparation of the immunogen and the coating source: the hapten is coupled to the protein by the activated ester method to prepare the immunogen and the coating source respectively;

单克隆抗体的制备:用所述免疫原制备单克隆抗体,用包被原通过ic-ELISA检测单克隆抗体的灵敏度和特异性,得到抗氟虫腈及其代谢物的单克隆抗体;Preparation of monoclonal antibody: use the immunogen to prepare monoclonal antibody, use the coating source to detect the sensitivity and specificity of the monoclonal antibody by ic-ELISA, and obtain the monoclonal antibody against fipronil and its metabolites;

金标抗体的制备:将所述单克隆抗体用胶体金标记制备得到金标抗体;Preparation of gold-labeled antibody: labeling the monoclonal antibody with colloidal gold to prepare gold-labeled antibody;

胶体金试纸条的制备:用氟虫腈偶联蛋白质的包被原在硝酸纤维素膜上制作检测线,以二抗在硝酸纤维素膜上制作质控线,然后组装成试纸条。Preparation of colloidal gold test strips: use fipronil-coupled protein-coated originals to make detection lines on nitrocellulose membranes, use secondary antibodies to make quality control lines on nitrocellulose membranes, and then assemble them into test strips.

上述方案中,所述半抗原的制备具体为:In the above scheme, the preparation of the hapten is specifically:

将氟虫腈溶于浓硫酸、乙酸和水中,加热回流,然后滴加氢氧化钠水溶液,直到pH达到碱性,加纯水溶解沉淀物,用正己烷洗涤水溶液,分液酸化水层溶液,直到pH到酸性,然后用乙酸乙酯萃取,合并有机相,用饱和的盐水洗涤,经无水硫酸钠干燥,减压蒸发,过硅胶柱,得到白色固体,即为半抗原。Dissolve fipronil in concentrated sulfuric acid, acetic acid and water, heat to reflux, then add aqueous sodium hydroxide solution dropwise until the pH reaches alkalinity, add pure water to dissolve the precipitate, wash the aqueous solution with n-hexane, separate and acidify the aqueous layer solution, Until the pH becomes acidic, then extract with ethyl acetate, combine the organic phases, wash with saturated brine, dry over anhydrous sodium sulfate, evaporate under reduced pressure, and pass through a silica gel column to obtain a white solid, which is the hapten.

上述方案中,所述浓硫酸的质量分数为98%;In such scheme, the massfraction of described concentrated sulfuric acid is 98%;

所述氟虫腈、浓硫酸、乙酸、水用量比为300~500mg:1~4mL:1~3mL:1~2mL;The dosage ratio of said fipronil, concentrated sulfuric acid, acetic acid and water is 300~500mg:1~4mL:1~3mL:1~2mL;

所述纯水和沉淀物的用量比为2~3mL:200~600mg。The usage ratio of the pure water and the precipitate is 2-3mL:200-600mg.

上述方案中,所述免疫原和包被原的制备具体为:In the above scheme, the preparation of the immunogen and the coating agent is specifically:

半抗原的活化:将所述半抗原溶于二甲基甲酰胺DMF中,向其中加入N-羟基琥珀酰亚胺NHS和1-乙基碳二亚胺盐酸盐EDC,并将混合物搅拌活化,得到已活化的半抗原;Activation of hapten: Dissolve the hapten in dimethylformamide DMF, add N-hydroxysuccinimide NHS and 1-ethylcarbodiimide hydrochloride EDC to it, and stir the mixture to activate , to obtain the activated hapten;

免疫原的制备:将牛血清白蛋白BSA充分地溶解在碳酸盐缓冲液CBS中,得到BSA溶液,在磁力搅拌下将已活化的半抗原溶液逐滴地加到BSA溶液中,将混合物搅拌反应,得到免疫原,免疫原用磷酸盐缓冲PBS透析;Preparation of immunogen: fully dissolve bovine serum albumin BSA in carbonate buffer CBS to obtain a BSA solution, add the activated hapten solution dropwise to the BSA solution under magnetic stirring, and stir the mixture React to obtain the immunogen, and the immunogen is dialyzed with phosphate-buffered PBS;

包被原的制备:将鸡卵清白蛋白OVA充分地溶解在碳酸盐缓冲液CBS中,得到OVA质溶液,在磁力搅拌下将已活化的半抗原溶液逐滴地加到OVA溶液中,将混合物搅拌反应,得到包被原,包被原用磷酸盐缓冲PBS透析。Preparation of coating source: Fully dissolve chicken ovalbumin OVA in carbonate buffer CBS to obtain OVA substance solution, add the activated hapten solution dropwise to the OVA solution under magnetic stirring, and put The mixture was reacted with stirring to obtain the coated original, which was dialyzed against phosphate buffered PBS.

上述方案中,所述半抗原的活化过程中,所述半抗原、DMF、NHS和EDC的用量比为 2~4mg:0.5~1mL:1~4mg:2~7mg;所述搅拌活化时间为6~8h。In the above scheme, during the activation process of the hapten, the dosage ratio of the hapten, DMF, NHS and EDC is 2-4mg: 0.5-1mL: 1-4mg: 2-7mg; the stirring activation time is 6 ~8h.

上述方案中,所述免疫原的制备过程中,所述BSA和CBS缓冲液的用量比为7~15mg: 3~5mL;In the above scheme, during the preparation of the immunogen, the dosage ratio of the BSA and CBS buffer is 7-15mg: 3-5mL;

所述包被原的制备过程中,所述OVA和CBS缓冲液的用量比为5~10mg:2~5mL;During the preparation of the coating agent, the dosage ratio of the OVA and CBS buffer solution is 5-10 mg:2-5 mL;

所述已活化的半抗原溶液中的半抗原与BSA溶液中的蛋白质的摩尔比,以及已活化的半抗原溶液中的半抗原与OVA溶液中的蛋白质的摩尔比均为20:1~40:1;The mol ratio of the hapten in the activated hapten solution to the protein in the BSA solution, and the mol ratio of the hapten in the activated hapten solution to the protein in the OVA solution are 20:1~40: 1;

所述搅拌反应的温度为4℃,搅拌反应的时间为12~18h;The temperature of the stirring reaction is 4° C., and the time of the stirring reaction is 12 to 18 hours;

所述PBS缓冲液透析时的温度为4℃,时间为36~78h。The temperature of the PBS buffer dialysis is 4° C., and the time is 36-78 hours.

上述方案中,所述金标抗体的制备具体为:In the above scheme, the preparation of the gold-labeled antibody is specifically as follows:

取纯水加热沸腾,在搅拌条件下加入氯金酸溶液,再加入柠檬酸三钠溶液,得到胶体金溶液;Take pure water and heat to boil, add chloroauric acid solution under stirring condition, then add trisodium citrate solution to obtain colloidal gold solution;

取胶体金溶液,加入硼酸缓冲液,充分混匀之后逐滴加入所述单克隆抗体溶液反应,然后逐滴加入10%BSA封闭,得到混合溶液;Take the colloidal gold solution, add boric acid buffer solution, mix well, then add the monoclonal antibody solution dropwise for reaction, and then add 10% BSA dropwise to block to obtain a mixed solution;

将所述混合溶液离心,弃去上清液,得到沉淀物,将所述沉淀物溶于重悬液中,得到金标抗体。The mixed solution is centrifuged, and the supernatant is discarded to obtain a precipitate, which is dissolved in the resuspension to obtain the gold-labeled antibody.

上述方案中,所述纯水、氯金酸溶液与柠檬酸三钠溶液的用量比500~900mL:1~2mL:1~3 mL;In the above-mentioned scheme, the consumption ratio of described pure water, chloroauric acid solution and trisodium citrate solution is 500~900mL:1~2mL:1~3 mL;

所述胶体金溶液、单克隆抗体溶液、硼酸缓冲液和10%BSA用量比是3~6mL:18~48μg: 300~600μL:200~800μL;The dosage ratio of the colloidal gold solution, monoclonal antibody solution, boric acid buffer solution and 10% BSA is 3~6mL:18~48μg: 300~600μL:200~800μL;

所述沉淀物和重悬液的用量比为0.1~1mg:300~500μL。The dosage ratio of the precipitate and the resuspension is 0.1-1 mg:300-500 μL.

上述方案中,所述胶体金试纸条的制备具体包括以下步骤:In the foregoing scheme, the preparation of the colloidal gold test strip specifically comprises the following steps:

将样品垫放进含有0.2%Tween-20、1%蔗糖和1%BSA的0.01M pH 7.4PBS溶液中浸泡后烘干;Soak the sample pad in a 0.01M pH 7.4 PBS solution containing 0.2% Tween-20, 1% sucrose and 1% BSA and then dry it;

将0.5~1mg/mL包被原喷涂在硝酸纤维素膜上作为检测线,将0.2~0.6mg/mL二抗喷涂在硝酸纤维素膜上作为质控线;Spray 0.5-1 mg/mL of the original coating on the nitrocellulose membrane as the detection line, and spray 0.2-0.6 mg/mL of the secondary antibody on the nitrocellulose membrane as the quality control line;

将所述样品垫、硝酸纤维素膜、吸水垫和底板进行组装。The sample pad, nitrocellulose membrane, absorbent pad and bottom plate were assembled.

一种检测氟虫腈及其代谢物的胶体金试纸条,根据所述检测氟虫腈及其代谢物的胶体金试纸条的检测方法制备。A colloidal gold test strip for detecting fipronil and its metabolites is prepared according to the detection method for the colloidal gold test strip for detecting fipronil and its metabolites.

与现有技术相比,本发明的有益效果是:Compared with prior art, the beneficial effect of the present invention is:

1.本发明通过酸水解法加入乙酸引入羧基,增加反应速率,制备得到半抗原,而后通过活化酯法偶联蛋白质制备免疫原性较强的免疫原,制备出能够同时识别氟虫腈及其代谢物的单克隆抗体,且抗体的灵敏度较高。1. The present invention adds acetic acid to introduce carboxyl groups through acid hydrolysis, increases the reaction rate, and prepares haptens, and then prepares immunogens with strong immunogenicity by coupling proteins with activated ester method, and prepares a compound that can simultaneously recognize fipronil and its Metabolite monoclonal antibody, and the sensitivity of the antibody is high.

2.本发明通过采用胶体金标记单克隆抗体制备的试纸条可同时检测氟虫腈及其毒性更强的代谢物,因此该方法在保障食品安全方面将更加具有意义和价值。2. The present invention can simultaneously detect fipronil and its more toxic metabolites by using the test strip prepared by colloidal gold-labeled monoclonal antibody, so this method will be more meaningful and valuable in ensuring food safety.

3.本发明制备的胶体金试纸条成本低、检测速度快、灵敏度高;该方法的检测结果可直接视觉判读,无需仪器的辅助,节省昂贵仪器的费用,且适宜现场大量样本的检测;直接将样本提取液与金标抗体孵育,插入试纸条,5min后即可判读检测结果;试验表明该检测方法灵敏度高。3. The colloidal gold test strip prepared by the present invention is low in cost, fast in detection speed and high in sensitivity; the detection result of the method can be directly visually interpreted without the assistance of an instrument, saves the cost of expensive instruments, and is suitable for the detection of a large number of samples on site; Directly incubate the sample extract with the gold-labeled antibody, insert the test strip, and the test result can be interpreted after 5 minutes; the test shows that the detection method has high sensitivity.

4.本发明制备的胶体金试纸条操作简单、适用性广;检测方法简单易懂,无需专业人员操作,可适用于执法部门、养殖户、消费者等人群使用。另外,该方法能为消费者的生命安全提供一定保障。4. The colloidal gold test strip prepared by the present invention is simple to operate and has wide applicability; the detection method is simple and easy to understand, does not require professional operation, and can be used by law enforcement agencies, farmers, consumers and other groups. In addition, this method can provide a certain guarantee for the life safety of consumers.

附图说明Description of drawings

本发明的上述和/或附加的方面和优点从结合下面附图对实施例的描述中将变得明显和容易理解,其中:The above and/or additional aspects and advantages of the present invention will become apparent and understandable from the description of the embodiments in conjunction with the following drawings, wherein:

图1中图1A为本发明胶体金试纸条的结构示意图;图1B为胶体金试纸条原理图。In Fig. 1, Fig. 1A is a schematic structural view of a colloidal gold test strip of the present invention; Fig. 1B is a schematic diagram of a colloidal gold test strip.

图2为胶体金紫外图;其中插图为胶体金的TEM图。Figure 2 is the UV image of colloidal gold; the inset is the TEM image of colloidal gold.

图3为抗体间接竞争抑制曲线。Figure 3 is the antibody indirect competition inhibition curve.

图4为胶体金试纸条检测氟虫腈及其代谢物残留的效果图。Fig. 4 is an effect diagram of detecting fipronil and its metabolite residues by colloidal gold test strips.

具体实施方式Detailed ways

下面结合附图详细描述本发明的实施例,下面通过参考附图描述的实施例是示例性的,旨在用于解释本发明,而不能理解为对本发明的限制。The embodiments of the present invention will be described in detail below in conjunction with the accompanying drawings. The embodiments described below with reference to the accompanying drawings are exemplary and intended to explain the present invention, but should not be construed as limiting the present invention.

本发明所述检测氟虫腈及其代谢物的胶体金试纸条的制备方法,包括以下步骤:The preparation method of the colloidal gold test strip for detecting fipronil and its metabolites of the present invention comprises the following steps:

(1)半抗原的制备:将适量的氟虫腈溶于浓硫酸、乙酸和水中,加热回流2~3h,然后滴加氢氧化钠水溶液,直到pH达到9~10,加纯水溶解沉淀物,用5~15mL正己烷洗涤水溶液,分液酸化水层溶液,直到pH到1,然后用乙酸乙酯萃取,合并有机相,用饱和的盐水洗涤,经无水硫酸钠干燥,减压蒸发。过硅胶柱,得到白色固体,即为半抗原;(1) Preparation of hapten: Dissolve an appropriate amount of fipronil in concentrated sulfuric acid, acetic acid and water, heat and reflux for 2-3 hours, then add aqueous sodium hydroxide solution dropwise until the pH reaches 9-10, add pure water to dissolve the precipitate , wash the aqueous solution with 5-15mL of n-hexane, separate and acidify the aqueous solution until the pH reaches 1, then extract with ethyl acetate, combine the organic phases, wash with saturated brine, dry over anhydrous sodium sulfate, and evaporate under reduced pressure. Pass through a silica gel column to obtain a white solid, which is the hapten;

所述浓硫酸的质量分数为98%;The massfraction of described concentrated sulfuric acid is 98%;

所述氟虫腈、浓硫酸、乙酸、水用量比为300~500mg:1~4mL:1~3mL:1~2mL;The dosage ratio of said fipronil, concentrated sulfuric acid, acetic acid and water is 300~500mg:1~4mL:1~3mL:1~2mL;

所述纯水和沉淀物的用量比为2~3mL:200~600mg。The usage ratio of the pure water and the precipitate is 2-3mL:200-600mg.

(2)免疫原和包被原的制备:(2) Preparation of immunogen and coating agent:

半抗原的活化:将半抗原的制备步骤中得到的半抗原溶于二甲基甲酰胺DMF中,向其中加入N-羟基琥珀酰亚胺NHS和1-乙基碳二亚胺盐酸盐EDC,并将混合物在室温下搅拌,得到已活化的半抗原;Hapten activation: The hapten obtained in the hapten preparation step is dissolved in dimethylformamide DMF, and N-hydroxysuccinimide NHS and 1-ethylcarbodiimide hydrochloride EDC are added thereto , and the mixture was stirred at room temperature to obtain an activated hapten;

免疫原的制备:将牛血清白蛋白BSA充分地溶解在碳酸盐缓冲液CBS中,得到BSA溶液,然后在磁力搅拌下将已活化的半抗原溶液逐滴地加到BSA溶液中,将混合物在一定温度条件下进行搅拌反应,得到免疫原;Preparation of immunogen: fully dissolve bovine serum albumin BSA in carbonate buffer CBS to obtain a BSA solution, then add the activated hapten solution to the BSA solution drop by drop under magnetic stirring, and the mixture Perform stirring reaction under certain temperature conditions to obtain the immunogen;

包被原的制备:将鸡卵清白蛋白OVA充分地溶解在碳酸盐缓冲液CBS中,得到OVA质溶液,然后在磁力搅拌下将已活化的半抗原溶液逐滴地加到OVA溶液中,将混合物在一定温度条件下进行搅拌反应,得到包被原;免疫原和包被原分别用磷酸盐缓冲PBS透析,并在透析过程中将透析液更换8次,透析结束后分装并于-20℃保存备用。Preparation of coating source: fully dissolve chicken ovalbumin OVA in carbonate buffer CBS to obtain OVA substance solution, and then add the activated hapten solution to the OVA solution drop by drop under magnetic stirring, The mixture was stirred and reacted under certain temperature conditions to obtain the coating source; the immunogen and the coating source were dialyzed with phosphate-buffered PBS respectively, and the dialysate was changed 8 times during the dialysis process. Store at 20°C for later use.

所述半抗原、DMF、NHS和EDC的用量比为2~4mg:0.5~1mL:1~4mg:2~7mg;所述搅拌时间为6~8h;The dosage ratio of the hapten, DMF, NHS and EDC is 2-4mg: 0.5-1mL: 1-4mg: 2-7mg; the stirring time is 6-8h;

所述免疫原的制备过程中,所述BSA和CBS缓冲液的用量比为7~15mg:3~5mL;During the preparation of the immunogen, the dosage ratio of the BSA and CBS buffer is 7-15 mg: 3-5 mL;

所述包被原的制备过程中,所述OVA和CBS缓冲液的用量比为5~10mg:2~5mL;During the preparation of the coating agent, the dosage ratio of the OVA and CBS buffer solution is 5-10 mg:2-5 mL;

所述已活化的半抗原溶液中的半抗原与BSA溶液中的蛋白质的摩尔比,以及已活化的半抗原溶液中的半抗原与OVA溶液中的蛋白质的摩尔比均为20:1~40:1;The mol ratio of the hapten in the activated hapten solution to the protein in the BSA solution, and the mol ratio of the hapten in the activated hapten solution to the protein in the OVA solution are 20:1~40: 1;

所述搅拌反应的温度为4℃,搅拌反应的时间为12~18h;The temperature of the stirring reaction is 4° C., and the time of the stirring reaction is 12 to 18 hours;

所述PBS缓冲液透析时的温度为4℃,时间为36~78h;The temperature during dialysis of the PBS buffer solution is 4°C, and the time is 36-78 hours;

所述BSA、OVA购自上海Sigma-Aldrich化学试剂公司,氟虫腈购自上海百灵威生物试剂有限公司。The BSA and OVA were purchased from Shanghai Sigma-Aldrich Chemical Reagent Company, and fipronil was purchased from Shanghai Bailingwei Biological Reagent Co., Ltd.

(3)单克隆抗体的制备:将制备得到的免疫原用生理盐水稀释至1~2mg/mL,然后和等体积的弗氏完全佐剂混合后分乳化;通过背部皮下多点注射的方式给小鼠(Balb/C)免疫,每只小鼠的免疫量是75~100μg;(3) Preparation of monoclonal antibody: Dilute the prepared immunogen to 1-2 mg/mL with normal saline, then mix it with an equal volume of Freund's complete adjuvant and emulsify it; Mice (Balb/C) were immunized, and the amount of immunization for each mouse was 75-100 μg;

之后每隔三周对小鼠进行加强免疫,将稀释至2mg/mL的免疫原和等体积的弗氏不完全佐剂充分乳化,通过背部皮下多点注射的方式给小鼠(Balb/C)免疫,每只小鼠的免疫量是 25~50μg。Afterwards, the mice were boosted every three weeks, and the immunogen diluted to 2 mg/mL and an equal volume of Freund's incomplete adjuvant were fully emulsified, and the mice were injected subcutaneously at multiple points on the back (Balb/C) For immunization, the immune dose per mouse was 25-50 μg.

从第三次免疫开始,对小鼠进行尾部采血检测;筛选出效价高和抑制率高的小鼠进行腹腔注射20μg的免疫原;注射三天后将该小鼠拉颈处死,浸泡在75%酒精中10min,在无菌的条件下取其脾脏细胞,将脾脏于铜网上充分的研磨,然后用PRMI-1640培养基冲洗三遍,得到细胞悬液于1200r/min条件下离心10min;弃上清液,再用PRMI-1640培养基重悬沉淀的细胞,进行离心,按照上述操作重复三次后对脾细胞进行计数;From the third immunization, the mice were tested by tail blood sampling; the mice with high titer and high inhibition rate were screened out and 20 μg of immunogen was injected intraperitoneally; three days after the injection, the mice were killed by pulling the neck and soaked in 75% After soaking in alcohol for 10 minutes, take the spleen cells under sterile conditions, grind the spleen well on a copper grid, and then wash it three times with PRMI-1640 medium, and centrifuge the cell suspension at 1200r/min for 10 minutes; Supernatant, and then use PRMI-1640 medium to resuspend the precipitated cells, centrifuge, and count the spleen cells after repeating the above operation three times;

按照小鼠脾细胞和骨髓瘤细胞10:1的比例将两者充分混匀,得到混合溶液于1200r/min 条件下离心10min,振荡、使离心管底部是细胞分散开来,在第一分钟内缓慢的加入的 PEG4000,静置1min后加入的PRMI-1640培养基以终止PEG的作用;所述混合溶液、PEG4000、 PRMI-1640培养基的用量比0.5mL:10mL。将融合的细胞静置放于37℃烘箱中培养15min,然后于3500r/min下离心10min。然后用含有10%胎牛血清的HAT的完全培养基重悬细胞,混匀后加入到96孔板的中,并置于37℃、5%CO2培养箱中进行培养。用包被原采用间接竞争ic-ELISA法对上清液筛选,选择抑制率高、阳性强的细胞孔进行亚克隆,而后再进行扩大培养,进行2~3次亚克隆后,获得纯度高的阳性杂交瘤细胞株。According to the 10:1 ratio of mouse splenocytes and myeloma cells, the two were fully mixed, and the mixed solution was centrifuged at 1200r/min for 10 minutes, and the cells were dispersed at the bottom of the centrifuge tube. Add PEG4000 slowly, and add PRMI-1640 medium after standing for 1min to terminate the effect of PEG; the dosage ratio of the mixed solution, PEG4000, and PRMI-1640 medium is 0.5mL: 10mL. The fused cells were cultured in a 37°C oven for 15 minutes, and then centrifuged at 3500 r/min for 10 minutes. Then the cells were resuspended with the complete medium of HAT containing 10% fetal bovine serum, mixed evenly and added to the 96-well plate, and placed in a 37°C, 5% CO 2 incubator for cultivation. The supernatant was screened by the indirect competitive ic-ELISA method with the coating original, and the cell wells with high inhibition rate and strong positive were selected for subcloning, and then expanded culture. After 2 to 3 times of subcloning, high purity cells were obtained Positive hybridoma cell lines.

腹水的制备和纯化:将上述筛选的杂交瘤细胞用PRMI-1640培养基稀释至每毫升的1× 106细胞的杂交瘤细胞,每只小鼠注射按照500~800uL进行腹腔注射,小鼠腹部肿大,采集腹水于3500r/min离心10min,收集上清液进行正辛酸-硫酸铵纯化,得到单克隆抗体。Preparation and purification of ascites: Dilute the above-screened hybridoma cells with PRMI-1640 medium to 1×10 6 hybridoma cells per milliliter, and inject 500-800uL into each mouse intraperitoneally. Swelling, ascites was collected and centrifuged at 3500r/min for 10min, and the supernatant was collected for n-octanoic acid-ammonium sulfate purification to obtain monoclonal antibodies.

所述正辛酸-硫酸铵纯化的具体操作为:取抗血清1mL,用0.06mol/L、pH 5.0的醋酸缓冲液稀释2倍,用1mol/L HCl溶液调pH至4.5;按照33μL/mL原始血清的比例,室温搅拌下逐滴缓慢加入正辛酸,4℃静置2h以上,使杂蛋白充分沉淀,于4℃、9000r/min离心30min,弃沉淀,收集上清液并用滤纸过滤,加入体积为上清液体积的1/10的0.1mol/L、pH7.4PBS,并将溶液pH调至7.4,按每毫升0.277g加入硫酸铵,搅拌均匀,4℃静置4h以上。而后于4℃、9000r/min离心30min,弃上清,收集沉淀,将沉淀溶于一定体积的PBS中,并在4℃条件下置于1L的PBS中透析以除盐,透析3~4天,每天更换3次透析液。The specific operation for the purification of n-octanoic acid-ammonium sulfate is as follows: take 1 mL of antiserum, dilute it twice with 0.06 mol/L, pH 5.0 acetate buffer, adjust the pH to 4.5 with 1 mol/L HCl solution; For the ratio of serum, slowly add n-octanoic acid drop by drop under stirring at room temperature, let stand at 4°C for more than 2 hours to fully precipitate the miscellaneous proteins, centrifuge at 4°C, 9000r/min for 30min, discard the precipitate, collect the supernatant and filter it with filter paper, add volume 0.1mol/L, pH7.4PBS, which is 1/10 of the volume of the supernatant, and adjust the pH of the solution to 7.4, add ammonium sulfate at 0.277g per ml, stir well, and stand at 4°C for more than 4h. Then centrifuge at 4°C and 9000r/min for 30min, discard the supernatant, collect the precipitate, dissolve the precipitate in a certain volume of PBS, and dialyze in 1L of PBS at 4°C to remove salt, and dialyze for 3 to 4 days , changing the dialysate 3 times a day.

(4)金标抗体的制备:取500~900mL的超纯水于烧瓶中于102℃中加热沸腾平衡30~50 min,于磁力搅拌下加入10%氯金酸溶液,10min后加入10%柠檬酸三钠溶液,继续搅拌直至溶液颜色变成深红色且不变色,得到胶体金溶液,冷却至室温于阴暗处保存备用。取3~6mL 的胶体金溶液,加入pH 8.5的硼酸缓冲液,充分混匀之后逐滴加入制备的单克隆抗体溶液反应30~60min。然后向上述溶液中逐滴加入10%BSA来封闭没有结合的位点,且室温下孵育0.5~1h。将该混合溶液于4℃,10000r/min下离心25min以除去没有结合的抗体和金纳米粒子,弃去上清液,将沉淀物溶于重悬液,重悬液含2%BSA、1%蔗糖、0.02%叠氮化钠的PBS 溶液中,并于4℃下保存备用。将上述制备的金标抗体稀释20~50倍,取50μL于96孔板中进行冷冻干燥备用。将二抗和制备的包被原分别用喷膜仪喷涂在硝酸纤维素膜上作为质控线 (C线)和检测线(T线),并于37℃烘箱过夜备用。(4) Preparation of gold-labeled antibody: Take 500-900mL of ultrapure water in a flask, heat and boil at 102°C for 30-50 minutes, add 10% chloroauric acid solution under magnetic stirring, and add 10% lemon after 10 minutes Trisodium acid solution, continue to stir until the color of the solution turns dark red and does not change color, to obtain a colloidal gold solution, cool to room temperature and store in a dark place for later use. Take 3-6mL of colloidal gold solution, add boric acid buffer solution with pH 8.5, mix well, then add the prepared monoclonal antibody solution drop by drop to react for 30-60min. Then 10% BSA was added dropwise to the above solution to block unbound sites, and incubated at room temperature for 0.5-1 h. Centrifuge the mixed solution at 10000r/min for 25min at 4°C to remove unbound antibodies and gold nanoparticles, discard the supernatant, and dissolve the precipitate in a resuspension containing 2% BSA, 1% Sucrose, 0.02% sodium azide in PBS solution, and stored at 4°C for later use. The gold-labeled antibody prepared above was diluted 20-50 times, and 50 μL was taken in a 96-well plate for freeze-drying for later use. The secondary antibody and the prepared coating source were sprayed on the nitrocellulose membrane as the quality control line (C line) and the detection line (T line) with a film sprayer, and were kept in an oven at 37°C overnight for later use.

所述纯水、氯金酸溶液与柠檬酸三钠溶液的用量比500~900mL:1~2mL:1~3mL;The consumption ratio of described pure water, chloroauric acid solution and trisodium citrate solution is 500~900mL:1~2mL:1~3mL;

所述胶体金溶液、单克隆抗体、硼酸缓冲液和10%BSA用量比是3~6mL:18~48μg:300~600μL:200~800μL;The dosage ratio of the colloidal gold solution, monoclonal antibody, boric acid buffer and 10% BSA is 3~6mL:18~48μg:300~600μL:200~800μL;

所述沉淀物和重悬液的用量比为0.1~1mg:300~500μL;The dosage ratio of the precipitate and the resuspension is 0.1-1 mg:300-500 μL;

所述二抗为HRP-羊抗鼠IgG购自于上海生工生物工程有限公司。The secondary antibody is HRP-goat anti-mouse IgG purchased from Shanghai Sangon Bioengineering Co., Ltd.

(5)胶体金试纸条的制备:用氟虫腈偶联蛋白质的包被原在硝酸纤维素膜上制作检测线,以二抗在硝酸纤维素膜上制作质控线,然后组装成试纸条。具体的,该试纸条包括样品垫、硝酸纤维素膜(NC膜)、吸水垫和底板,将NC膜贴在底板的中间,吸水垫和样品垫分别贴在底板的上下两边,与NC膜重叠2~3mm。用喷膜仪分别将0.3~1mg/mL的二抗和0.5~1mg /mL所述包被源喷在NC膜上作为C线和T线,然后用切条机将其切成3.8~4mm长的试纸条,放入自封袋于干燥箱中保存备用。(5) Preparation of colloidal gold test strips: use fipronil-coupled protein coatings to make detection lines on nitrocellulose membranes, use secondary antibodies to make quality control lines on nitrocellulose membranes, and then assemble them into test strips. note. Specifically, the test strip includes a sample pad, a nitrocellulose membrane (NC membrane), an absorbent pad and a bottom plate, and the NC membrane is pasted in the middle of the bottom plate, and the water-absorbent pad and the sample pad are respectively pasted on the upper and lower sides of the bottom plate. Overlap 2-3mm. Spray 0.3-1 mg/mL of secondary antibody and 0.5-1 mg/mL of the coating source on the NC film as C line and T line with a film sprayer, and then cut it into 3.8-4 mm long with a strip cutter The test strips were put into a ziplock bag and stored in a dry box for later use.

氟虫腈及其代谢物的检测:将样本提取液与所述金标抗体孵育,插入所述试纸条进行检测。Detection of fipronil and its metabolites: incubate the sample extract with the gold-labeled antibody, insert the test strip for detection.

实施例1Example 1

如图1A所示,本发明的能同时检测氟虫腈及其代谢物的胶体金试纸条,是以底板(PVC) 为支撑,两者的中间部分是硝酸纤维素膜,且该膜上有质控线和检测线,左边的样品垫和右边的吸水垫分别与硝酸纤维素膜搭接。质控线上喷涂的是辣根过氧化物酶标记的二抗,检测线上喷涂的是合成的包被原。96孔板中的是胶体金标记氟虫腈单克隆抗体的偶联物。As shown in Figure 1A, the colloidal gold test strip of the present invention that can detect fipronil and its metabolites simultaneously is supported by a base plate (PVC), and the middle part of the two is a nitrocellulose membrane, and on the membrane There are quality control lines and detection lines, the sample pad on the left and the absorbent pad on the right are respectively lapped with the nitrocellulose membrane. The quality control line is sprayed with horseradish peroxidase-labeled secondary antibody, and the detection line is sprayed with a synthetic coating agent. The 96-well plate is a conjugate of colloidal gold-labeled fipronil monoclonal antibody.

所述的试纸条中的样品垫的材料的主要成分是玻璃纤维膜,底板是聚氯乙烯材料。样品垫最左边有一层箭头朝下的贴纸,以指示试纸条插进样本提取液的方向。The main component of the material of the sample pad in the test strip is glass fiber membrane, and the bottom plate is polyvinyl chloride material. The leftmost side of the sample pad has a layer of stickers with an arrow pointing down to indicate the direction in which the test strip is inserted into the sample extraction solution.

实施例2Example 2

要制备能同时快速检测氟虫腈及其代谢物的胶体金试纸条,首先要制备免疫原性强的免疫原和抗氟虫腈及其代谢物的单克隆抗体,然后进行试纸条组装和制备。具体操作步骤如下:To prepare colloidal gold test strips that can rapidly detect fipronil and its metabolites at the same time, it is first necessary to prepare immunogens with strong immunogenicity and monoclonal antibodies against fipronil and its metabolites, and then assemble the test strips and preparation. The specific operation steps are as follows:

(1)半抗原的制备:采用酸水解法将氟虫腈上的氰基水解为羧基。称取437mg、1mmoL 的氟虫腈,加入2.5mL乙酸和1.25mL、98%的浓硫酸、1.5mL水,充分混合均匀后将混合物加热回流3h。而后冷却至室温,在0℃的条件下缓慢地逐滴加入1M氢氧化钠溶液,将该溶液的pH调至10后,加入3mL水溶解沉淀物,用10mL正己烷洗涤该水溶液。分液后收集水层溶液,用1M盐酸溶液酸化,直到pH达到1,然后用3×15mL乙酸乙酯萃取。合并所有的有机相,用15mL饱和盐水洗涤,经无水硫酸钠干燥,减压蒸发去除有机溶剂。最后过硅胶柱,得到白色固体。(1) Preparation of hapten: the cyano group on fipronil was hydrolyzed into carboxyl group by acid hydrolysis method. Weigh 437mg, 1mmoL of fipronil, add 2.5mL acetic acid, 1.25mL, 98% concentrated sulfuric acid, 1.5mL water, mix thoroughly and heat the mixture to reflux for 3h. Then cool to room temperature, slowly add 1M sodium hydroxide solution dropwise at 0°C, adjust the pH of the solution to 10, add 3 mL of water to dissolve the precipitate, and wash the aqueous solution with 10 mL of n-hexane. After separation, the aqueous layer solution was collected, acidified with 1M hydrochloric acid solution until the pH reached 1, and then extracted with 3×15 mL ethyl acetate. All organic phases were combined, washed with 15 mL of saturated brine, dried over anhydrous sodium sulfate, and evaporated under reduced pressure to remove the organic solvent. Finally, it was passed through a silica gel column to obtain a white solid.

(2)免疫原和包被原的制备:将3mg半抗原溶于1mL DMF中,向其中加入2.2mg NHS和4mg EDC,并将混合物在室温下搅拌6h。将14mg BSA和10mg OVA分别充分地溶解在5mLCBS缓冲液中,然后在磁力搅拌下将已活化的半抗原溶液分别逐滴地加到BSA溶液和OVA溶液中。将混合物在4℃下搅拌反应12h,得到免疫原和包被原,将免疫原和包被原分别在4℃下用PBS缓冲液透析72小时,并在透析过程中将透析液更换8次,透析结束后分装保存于-20℃保存备用。(2) Preparation of immunogen and coating original: 3 mg of hapten was dissolved in 1 mL of DMF, 2.2 mg of NHS and 4 mg of EDC were added thereto, and the mixture was stirred at room temperature for 6 h. 14mg BSA and 10mg OVA were fully dissolved in 5mL CBS buffer, respectively, and then the activated hapten solution was added dropwise to the BSA solution and the OVA solution under magnetic stirring. The mixture was stirred and reacted at 4°C for 12 hours to obtain the immunogen and the coating agent, which were dialyzed against PBS buffer at 4°C for 72 hours, and the dialysate was changed 8 times during the dialysis process. After dialysis, aliquots were stored at -20°C for future use.

(3)单克隆抗体的制备:小鼠的第一次免疫(首免)是将制备好的免疫原用生理盐水稀释至2mg/mL,然后和等体积的弗氏完全佐剂混合,用乳化器充分乳化。而后以背部皮下多点注射的方式给Balb/C小鼠免疫,每只小鼠的免疫量是100μg。之后每隔三周对小鼠进行加强免疫,将稀释至2mg/mL的免疫原和等体积的弗氏不完全佐剂充分乳化,采用与首免相同的方式进行免疫,每只小鼠的免疫量是50μg。从第三次免疫开始,对小鼠进行尾部采血检测。筛选出效价高和抑制率高的小鼠进行冲免即腹腔注射20μg的免疫原。三天后将该小鼠拉颈处死,浸泡在75%酒精中10min,在无菌的条件下取其脾脏细胞,用注射器芯将脾脏于铜网上充分的研磨,然后用PRMI-1640培养基冲洗三遍,将细胞悬液与50mL离心管中1200r/min,离心10min。弃上清液,用PRMI-1640培养基重悬沉淀的细胞,按照上述操作重复三次后对脾细胞进行计数。按照小鼠脾细胞和骨髓瘤细胞10:1的比例将两者充分的混匀后于50mL离心管中1200r/min,离心10min,轻轻地弹离心管底部是细胞分散开来,在第一分钟内缓慢的加入1mL的PEG4000,静置1min后加入10mL的PRMI-1640培养基以终止PEG的作用。将融合的细胞静置放于37℃烘箱中15min,然后于800r/min下离心10min。然后用含有15%胎牛血清的HAT的完全培养基重悬细胞,混匀后加入到96孔板的中,并置于37℃、5%的 CO2培养箱中进行培养。用间接竞争ELISA法对上清液筛选,选择抑制率高、阳性强的细胞孔进行亚克隆,而后进行扩大培养,需进行2~3次亚克隆以获得纯度高的阳性杂交瘤细胞株。(3) Preparation of monoclonal antibody: The first immunization (first immunization) of mice is to dilute the prepared immunogen to 2mg/mL with normal saline, then mix it with an equal volume of Freund's complete adjuvant, and use emulsifying fully emulsified. Then Balb/C mice were immunized by multi-point subcutaneous injection on the back, and the immune dose of each mouse was 100 μg. Afterwards, the mice were boosted every three weeks, and the immunogen diluted to 2 mg/mL and an equal volume of Freund's incomplete adjuvant were fully emulsified, and the same method as the first immunization was used for immunization. The immunization of each mouse The amount is 50 μg. From the third immunization, mice were tested by tail blood sampling. Mice with high titer and high inhibition rate were screened out for flushing, that is, 20 μg of immunogen was injected intraperitoneally. Three days later, the mouse was killed by pulling the neck, soaked in 75% alcohol for 10 minutes, and its spleen cells were taken under sterile conditions, and the spleen was fully ground on the copper grid with a syringe core, and then washed with PRMI-1640 medium for three times. For each time, the cell suspension was centrifuged at 1200r/min in a 50mL centrifuge tube for 10min. Discard the supernatant, resuspend the precipitated cells with PRMI-1640 medium, and count the splenocytes after repeating the above operation three times. According to the 10:1 ratio of mouse splenocytes and myeloma cells, the two were fully mixed, then centrifuged at 1200r/min in a 50mL centrifuge tube for 10min, and the cells were dispersed by flicking the bottom of the centrifuge tube gently. Slowly add 1 mL of PEG4000 within 1 minute, and add 10 mL of PRMI-1640 medium after standing for 1 minute to terminate the effect of PEG. The fused cells were placed in an oven at 37°C for 15 minutes, and then centrifuged at 800 r/min for 10 minutes. Then the cells were resuspended with the complete HAT medium containing 15% fetal bovine serum, mixed evenly, added to the 96-well plate, and placed in a 37°C, 5% CO2 incubator for cultivation. The supernatant was screened by indirect competitive ELISA method, and the cell wells with high inhibition rate and strong positivity were selected for subcloning, and then expanded and cultured. Two to three times of subcloning were required to obtain high-purity positive hybridoma cell lines.

腹水的制备和纯化:将上述筛选的杂交瘤细胞用PRMI-1640培养基稀释至每毫升的1× 106细胞的杂交瘤细胞,每只小鼠注射按照800uL进行腹腔注射,小鼠腹部肿大,用5mL的注射器采集腹水于3500r/min离心10min,收集上清液进行正辛酸-硫酸铵纯化。取抗血清1mL,用0.06mol/L、pH 5.0的醋酸缓冲液稀释2倍,用1mol/L HCl溶液调pH至4.5;按照33μL/mL原始血清的比例,室温搅拌下逐滴缓慢加入正辛酸,4℃静置2h以上,使杂蛋白充分沉淀,于4℃、9000r/min离心30min,弃沉淀,收集上清液并用滤纸过滤,加入体积为上清液体积的1/10的0.1mol/L、pH 7.4的PBS,并将溶液pH调至7.4,按每毫升0.277g 加入硫酸铵,搅拌均匀,4℃静置4h以上。而后于4℃、9000r/min离心30min,弃上清,收集沉淀,将沉淀溶于一定体积的PBS中,并在4℃条件下置于1L的PBS中透析除盐,透析3~4天,每天更换3次透析液。Preparation and purification of ascites: Dilute the above-screened hybridoma cells with PRMI-1640 medium to 1×10 6 hybridoma cells per milliliter, inject 800uL intraperitoneally into each mouse, and the abdomen of the mouse is enlarged , collected ascitic fluid with a 5mL syringe, centrifuged at 3500r/min for 10min, and collected the supernatant for n-octanoic acid-ammonium sulfate purification. Take 1 mL of antiserum, dilute it twice with 0.06 mol/L, pH 5.0 acetate buffer, adjust the pH to 4.5 with 1 mol/L HCl solution; add n-octanoic acid drop by drop slowly under stirring at room temperature according to the ratio of 33 μL/mL of original serum , let stand at 4°C for more than 2 hours to fully precipitate the miscellaneous proteins, centrifuge at 4°C, 9000r/min for 30min, discard the precipitate, collect the supernatant and filter it with filter paper, add 0.1mol/ L. PBS with pH 7.4, adjust the pH of the solution to 7.4, add ammonium sulfate at 0.277g per ml, stir evenly, and stand at 4°C for more than 4h. Then centrifuge at 4°C and 9000r/min for 30min, discard the supernatant, collect the precipitate, dissolve the precipitate in a certain volume of PBS, and dialyze in 1L of PBS at 4°C to remove salt, and dialyze for 3 to 4 days. The dialysate was changed 3 times a day.

(4)抗体灵敏度和交叉率的测定:将浓度分别为0、0.1、0.3、0.9、2.7、8.1ng/mL的氟虫腈,浓度分别为0、0.05、0.15、0.45、1.35、4.05ng/mL的氟甲腈,浓度分别为0、0.1、0.3、0.9、2.7、8.1ng/mL的氟虫腈砜,浓度分别为0、0.1、0.3、0.9、2.7、8.1ng/mL的氟虫腈亚砜,用ic-ELISA方法测其半数抑制浓度(IC50),而后计算抗体交叉率。交叉率的计算公式如下:交叉率(%)=(氟虫腈IC50/类似物IC50)×100%。结果如表1和图3所示,氟虫腈抗体的IC50是0.44ng/mL,对氟虫腈亚砜、氟虫腈砜、氟甲腈的交叉率分别是69.84、75.86、112.82%。本发明制备的氟虫腈抗体的灵敏度比Development of an enzyme immunoassayfor detection of fipronil in environmental samples和Poly-and monoclonalantibody-based ELISAs for fipronil中抗体的灵敏度分别提高了700和14倍,且以上两篇文章中制备的抗体仅识别氟虫腈本身。综上说明本发明制备的抗体是同时识别氟虫腈及其三种代谢物,且灵敏度较高。(4) Determination of antibody sensitivity and crossover rate: the concentrations of fipronil were 0, 0.1, 0.3, 0.9, 2.7, 8.1ng/mL, respectively, and the concentrations were 0, 0.05, 0.15, 0.45, 1.35, 4.05ng/mL mL of fluformil at concentrations of 0, 0.1, 0.3, 0.9, 2.7, 8.1 ng/mL of fipronil sulfone, and concentrations of 0, 0.1, 0.3, 0.9, 2.7, 8.1 ng/mL of fipronil For sulfoxide, the half maximal inhibitory concentration (IC 50 ) was measured by ic-ELISA method, and then the antibody crossover rate was calculated. The formula for calculating the crossover rate is as follows: crossover rate (%)=(fipronil IC 50 /similar IC 50 )×100%. The results are shown in Table 1 and Figure 3. The IC 50 of the fipronil antibody was 0.44ng/mL, and the crossover rates to fipronil sulfoxide, fipronil sulfone, and fluformil were 69.84, 75.86, and 112.82%, respectively. The sensitivity of the fipronil antibody prepared by the present invention is 700 and 14 times higher than that of the antibody in Development of an enzyme immunoassay for detection of fipronil in environmental samples and Poly-and monoclonal antibody-based ELISAs for fipronil, respectively, and in the above two articles The prepared antibody only recognizes fipronil itself. In summary, the antibody prepared by the present invention recognizes fipronil and its three metabolites simultaneously, and has high sensitivity.

表1抗体交叉率的测定Table 1 Determination of Antibody Crossover Rate

Figure BDA0002368283450000091
Figure BDA0002368283450000091

(5)金标抗体的制备:取800mL的超纯水于烧瓶中于102℃中加热沸腾平衡30min,于磁力搅拌下加入1.6mL的10%氯金酸溶液,10min后加入2.08mL10%柠檬酸三钠溶液,继续搅拌直至溶液颜色变成深红色且不变色。冷却至室温保存备用。如图2所示,胶体金制备成功,胶体金颗粒大小均匀,计算其粒径大小为15nm左右,分散性较好,无聚集现象。取3mL的胶体金溶液,加入300μL的pH 8.5的硼酸缓冲液,充分混匀之后逐滴加入18μg 抗体溶液反应1h。然后向上述溶液中逐滴加入300μL10%BSA来封闭没有结合的位点来减少试验中的非特异性的吸附,且室温下孵育0.5h。将液于4℃,10000r/min下离心25min以除去未结合的抗体和胶体金,弃去上清液,将沉淀物溶于200μL重悬液中,所述重悬液为含 2%BSA、1%蔗糖、0.02%叠氮化钠的PBS溶液,该重悬液有利于对金标抗体的保护,而后4℃下保存备用。将上述制备的金标抗体稀释20倍,取50μL于96孔板中进行冷冻干燥备用。(5) Preparation of gold-labeled antibody: Take 800mL of ultrapure water in a flask and heat to boil at 102°C for 30min, add 1.6mL of 10% chloroauric acid solution under magnetic stirring, and add 2.08mL of 10% citric acid after 10min Trisodium solution, continue to stir until the color of the solution turns dark red and does not change color. Cool to room temperature and store for later use. As shown in Figure 2, the colloidal gold was successfully prepared, and the colloidal gold particles were uniform in size, and the calculated particle size was about 15nm, with good dispersion and no aggregation. Take 3mL of colloidal gold solution, add 300μL of pH 8.5 borate buffer, mix well, then add 18μg antibody solution drop by drop to react for 1h. Then, 300 μL of 10% BSA was added dropwise to the above solution to block unbound sites to reduce non-specific adsorption in the test, and incubated at room temperature for 0.5 h. Centrifuge the liquid at 4°C and 10000r/min for 25min to remove unbound antibody and colloidal gold, discard the supernatant, and dissolve the precipitate in 200μL of resuspension containing 2% BSA, 1% sucrose, 0.02% sodium azide in PBS solution, the resuspension is conducive to the protection of the gold-labeled antibody, and then stored at 4 ° C for use. The gold-labeled antibody prepared above was diluted 20 times, and 50 μL was taken in a 96-well plate for freeze-drying.

(6)试纸条的制备:将0.8mg/mL包被原和0.4mg/mL二抗分别用喷膜仪喷涂在NC 膜上作为T线和C线,并于37℃烘箱过夜备用而后按照图1A所示试纸条的结构进行组装。组装前将样品垫于0.2%Tween-20,1%蔗糖、1%BSA的0.01M、pH 7.4的PBS溶液中浸泡 30min后37℃烘干,该溶液有利于金标抗体向上爬升和与T线的包被原和C线的二抗结合。本发明的检测方法的规则:如图1B所示:取150μL的样本提取液加入至已冻干的金标抗体中,混合均匀后于室温下孵育3min,将试纸条插入孔中,五分钟后视觉判读检测结果,有利于待测物、金标抗体、包被源、二抗的充分结合,提高检测方法的灵敏度。根据毛细管作用,混合物向上爬升的时会由于抗原抗体特异性反应被C线的二抗和T线的包被原捕获而显色。若T线和C线颜色深度一致,则该样品中无待测物即为阴性结果。若T线的颜色深度比C线浅或者T线没有颜色,则该样品中含待测物即为阳性结果。若C线没有颜色,则表明该试纸条为失效产品。(6) Preparation of test strips: Spray 0.8mg/mL of the original coating material and 0.4mg/mL of the secondary antibody on the NC film as T-line and C-line with a film sprayer, and put them in an oven at 37°C overnight for later use. The test strip configuration shown in Figure 1A was assembled. Before assembly, soak the sample mat in 0.2% Tween-20, 1% sucrose, 1% BSA, 0.01M, pH 7.4 PBS solution for 30 minutes and then dry it at 37°C. This solution is conducive to the upward climbing of the gold-labeled antibody and the T line The coating primary and C-line secondary antibody binding. The rules of the detection method of the present invention: as shown in Figure 1B: Take 150 μL of the sample extract and add it to the lyophilized gold-labeled antibody, mix it evenly and incubate at room temperature for 3 minutes, insert the test strip into the hole, and wait for five minutes Post-visual interpretation of the test results is conducive to the full combination of the analyte, gold-labeled antibody, coating source, and secondary antibody, and improves the sensitivity of the detection method. According to capillary action, when the mixture rises upwards, it will develop color due to the specific reaction of the antigen and antibody being captured by the secondary antibody of the C line and the coating source of the T line. If the T line and C line have the same color depth, then there is no analyte in the sample, which is a negative result. If the color depth of the T line is lighter than that of the C line or the T line has no color, the sample contains the analyte, which is a positive result. If the C line has no color, it indicates that the test strip is an invalid product.

(7)试纸条检测限测定:取5g混合均匀的鸡蛋置于50mL离心管中,添加不同浓度的氟虫腈及其代谢物的标准品,氟虫腈、氟虫腈砜、氟虫腈亚砜均为:0、5、10、20ng/g;氟甲腈为:0、2.5、5、10ng/g,加入3g的中性氧化铝和5mL乙腈,然后剧烈震荡5min,在室温下以4000r/min离心3min,弃去沉淀物收集上清液。取1mL的上清液于2mL的离心管中,于60℃氮吹至有机试剂完全蒸发。将残留物重新溶解于1mL正己烷,再加入1mL的 0.01M PBS,在4000r/min离心3min,收集下层溶液。检测限定义为检测限定义为与阴性对照相比,T线颜色比C线浅的最低浓度。检测结果如图4所示:氟虫腈,氟虫腈亚砜、氟虫腈砜、氟甲腈的检测限分别是10、10、10、5ng/g。(7) Determination of the detection limit of test strips: Take 5g of eggs mixed evenly and place them in a 50mL centrifuge tube, add different concentrations of fipronil and its metabolites as standard products, fipronil, fipronil sulfone, fipronil Sulfoxide: 0, 5, 10, 20ng/g; fluoroformonitrile: 0, 2.5, 5, 10ng/g, add 3g of neutral alumina and 5mL of acetonitrile, shake vigorously for 5min, Centrifuge at 4000r/min for 3min, discard the precipitate and collect the supernatant. Take 1 mL of the supernatant in a 2 mL centrifuge tube and blow with nitrogen at 60°C until the organic reagent is completely evaporated. Redissolve the residue in 1mL of n-hexane, then add 1mL of 0.01M PBS, centrifuge at 4000r/min for 3min, and collect the lower layer solution. The limit of detection was defined as the lowest concentration at which the T line was lighter in color than the C line compared to the negative control. The detection results are shown in Figure 4: the detection limits of fipronil, fipronil sulfoxide, fipronil sulfone, and fluformil are 10, 10, 10, and 5 ng/g, respectively.

图3为抗体间接竞争抑制曲线,氟虫腈抗体的IC50是0.44ng/mL,对氟虫腈亚砜、氟虫腈砜、氟甲腈的交叉率分别是69.84、75.86、112.82%。说明本发明制备的抗体是能同时识别氟虫腈及其代谢物的单克隆抗体,且灵敏度较高。为制备能同时检测氟虫腈及其代谢物的胶体金试纸条提供强有力的条件。Figure 3 is the indirect competitive inhibition curve of the antibody. The IC 50 of the fipronil antibody is 0.44ng/mL, and the crossover rates to fipronil sulfoxide, fipronil sulfone, and fluformil are 69.84, 75.86, and 112.82%, respectively. It shows that the antibody prepared by the present invention is a monoclonal antibody capable of simultaneously recognizing fipronil and its metabolites, and has high sensitivity. Provide powerful conditions for the preparation of colloidal gold test strips that can simultaneously detect fipronil and its metabolites.

直接将样本提取液与金标抗体孵育3min,插入试纸条,5min后即可判读检测结果;试验表明该检测方法灵敏度高,氟虫腈、氟虫腈砜、氟虫腈亚砜、氟甲腈的检测限分别为10、10、10、5ng/g。Directly incubate the sample extract with the gold-labeled antibody for 3 minutes, insert the test strip, and the test result can be interpreted after 5 minutes; the test shows that the detection method has high sensitivity, and fipronil, fipronil sulfone, fipronil sulfoxide, The detection limits of nitriles were 10, 10, 10, 5 ng/g, respectively.

图4为胶体金试纸条检测氟虫腈及其代谢物残留的效果图。其中A、B、C为分别为氟虫腈、氟虫腈砜、氟虫腈亚砜,三者浓度梯度皆为0、5、10、20ng/g;D为氟甲腈,浓度梯度为0、2.5、5、10ng/g。图中试纸条检测结果表明氟虫腈,氟虫腈亚砜、氟虫腈砜、氟甲腈的检测限分别是10、10、10、5ng/g。Fig. 4 is an effect diagram of detecting fipronil and its metabolite residues by colloidal gold test strips. Among them, A, B, and C are respectively fipronil, fipronil sulfone, and fipronil sulfoxide, and the concentration gradients of the three are 0, 5, 10, and 20 ng/g; D is fluformil, and the concentration gradient is 0 , 2.5, 5, 10 ng/g. The detection results of the test strips in the figure show that the detection limits of fipronil, fipronil sulfoxide, fipronil sulfone, and fluformil are 10, 10, 10, and 5 ng/g, respectively.

上文所列出的一系列的详细说明仅仅是针对本发明的可行性实施例的具体说明,它们并非用以限制本发明的保护范围,凡未脱离本发明技艺精神所作的等效实施例或变更均应包含在本发明的保护范围之内。The series of detailed descriptions listed above are only specific descriptions for feasible embodiments of the present invention, and they are not intended to limit the protection scope of the present invention. Any equivalent embodiment or All changes should be included within the protection scope of the present invention.

Claims (6)

1.一种检测氟虫腈及其代谢物的胶体金试纸条制备方法,其特征在于,包括以下步骤:1. a colloidal gold test strip preparation method that detects fipronil and its metabolites, is characterized in that, comprises the following steps: 半抗原的制备:将氟虫腈通过酸水解法并加入乙酸,引入羧基,制备得到半抗原,所述半抗原的制备具体为:Preparation of hapten: fipronil is hydrolyzed by acid and acetic acid is added to introduce carboxyl group to prepare hapten. The preparation of said hapten is as follows: 将氟虫腈溶于浓硫酸、乙酸和水中,加热回流,然后滴加氢氧化钠水溶液,直到pH达到碱性,加纯水溶解沉淀物,用正己烷洗涤水溶液,分液酸化水层溶液,直到pH到酸性,然后用乙酸乙酯萃取,合并有机相,用饱和的盐水洗涤,经无水硫酸钠干燥,减压蒸发,过硅胶柱,得到白色固体,即为半抗原;所述浓硫酸的质量分数为98%;所述氟虫腈、浓硫酸、乙酸、水用量比为300~500mg:1~4mL:1~3mL:1~2mL;所述纯水和沉淀物的用量比为2~3 mL:200~600mg;Dissolve fipronil in concentrated sulfuric acid, acetic acid and water, heat to reflux, then add aqueous sodium hydroxide solution dropwise until the pH reaches alkaline, add pure water to dissolve the precipitate, wash the aqueous solution with n-hexane, separate and acidify the aqueous layer solution, until the pH becomes acidic, then extract with ethyl acetate, combine the organic phases, wash with saturated brine, dry over anhydrous sodium sulfate, evaporate under reduced pressure, and pass through a silica gel column to obtain a white solid, which is a hapten; the concentrated sulfuric acid The mass fraction is 98%; said fipronil, concentrated sulfuric acid, acetic acid, water consumption ratio is 300~500mg:1~4mL:1~3mL:1~2mL; the consumption ratio of described pure water and deposit is 2 ~3 mL: 200~600mg; 免疫原和包被原的制备:将所述半抗原通过活化酯法偶联蛋白质分别制备免疫原和包被原,所述免疫原和包被原的制备具体为:Preparation of the immunogen and the coating source: the hapten is coupled to the protein by the activated ester method to prepare the immunogen and the coating source respectively, and the preparation of the immunogen and the coating source is specifically as follows: 半抗原的活化:将所述半抗原溶于二甲基甲酰胺DMF中,向其中加入N-羟基琥珀酰亚胺NHS和1-乙基碳二亚胺盐酸盐EDC,并将混合物搅拌活化,得到已活化的半抗原;所述半抗原、DMF、NHS和EDC的用量比为2~4mg:0.5~1mL:1~4 mg:2~7 mg;所述搅拌活化时间为6~8h;Activation of hapten: Dissolve the hapten in dimethylformamide DMF, add N-hydroxysuccinimide NHS and 1-ethylcarbodiimide hydrochloride EDC to it, and stir the mixture to activate , to obtain the activated hapten; the dosage ratio of the hapten, DMF, NHS and EDC is 2~4mg: 0.5~1mL: 1~4 mg: 2~7 mg; the stirring activation time is 6~8h; 免疫原的制备:将牛血清白蛋白BSA充分地溶解在碳酸盐缓冲液CBS中,得到BSA溶液,在磁力搅拌下将已活化的半抗原溶液逐滴地加到BSA溶液中,将混合物搅拌反应,得到免疫原,免疫原用磷酸盐缓冲PBS透析;Preparation of immunogen: fully dissolve bovine serum albumin BSA in carbonate buffer CBS to obtain a BSA solution, add the activated hapten solution dropwise to the BSA solution under magnetic stirring, and stir the mixture React to obtain the immunogen, and the immunogen is dialyzed with phosphate-buffered PBS; 包被原的制备:将鸡卵清白蛋白OVA充分地溶解在碳酸盐缓冲液CBS中,得到OVA质溶液,在磁力搅拌下将已活化的半抗原溶液逐滴地加到OVA溶液中,将混合物搅拌反应,得到包被原,包被原用磷酸盐缓冲PBS透析;Preparation of coating source: Fully dissolve chicken ovalbumin OVA in carbonate buffer CBS to obtain OVA substance solution, add the activated hapten solution dropwise to the OVA solution under magnetic stirring, and put The mixture was stirred and reacted to obtain the coated original, which was dialyzed with phosphate buffered PBS; 单克隆抗体的制备:用所述免疫原制备单克隆抗体,用所述包被原通过ic-ELISA检测单Preparation of monoclonal antibody: use the immunogen to prepare monoclonal antibody, and use the coating original to detect monoclonal antibody by ic-ELISA 克隆抗体的灵敏度和特异性,得到抗氟虫腈及其代谢物的单克隆抗体;Sensitivity and specificity of cloned antibodies to obtain monoclonal antibodies against fipronil and its metabolites; 金标抗体的制备:将所述单克隆抗体用胶体金标记制备得到金标抗体;Preparation of gold-labeled antibody: labeling the monoclonal antibody with colloidal gold to prepare gold-labeled antibody; 胶体金试纸条的制备:用氟虫腈偶联蛋白质的包被原在硝酸纤维素膜上制作检测线,以二抗在硝酸纤维素膜上制作质控线,然后组装成试纸条。Preparation of colloidal gold test strips: use fipronil-coupled protein-coated originals to make detection lines on nitrocellulose membranes, use secondary antibodies to make quality control lines on nitrocellulose membranes, and then assemble them into test strips. 2.根据权利要求1所述的检测氟虫腈及其代谢物的胶体金试纸条制备方法,其特征在于,所述免疫原的制备过程中,所述BSA和CBS缓冲液的用量比为7~15mg:3~5 mL;2. the colloidal gold test strip preparation method that detects fipronil and its metabolites according to claim 1, is characterized in that, in the preparation process of described immunogen, the consumption ratio of described BSA and CBS damping fluid is 7~15mg: 3~5mL; 所述包被原的制备过程中,所述OVA和CBS缓冲液的用量比为5~10mg:2~5 mL;In the preparation process of the coating former, the dosage ratio of the OVA and the CBS buffer solution is 5-10 mg: 2-5 mL; 所述已活化的半抗原溶液中的半抗原与BSA溶液中的蛋白质的摩尔比,以及已活化的半抗原溶液中的半抗原与OVA溶液中的蛋白质的摩尔比均为20:1~40:1;The mol ratio of the hapten in the activated hapten solution to the protein in the BSA solution, and the mol ratio of the hapten in the activated hapten solution to the protein in the OVA solution are 20:1~40: 1; 所述搅拌反应的温度为4℃,搅拌反应的时间为12~18 h;The temperature of the stirring reaction is 4° C., and the time of the stirring reaction is 12 to 18 h; 所述PBS缓冲液透析时的温度为4℃,时间为36~78 h。The temperature of the PBS buffer dialysis was 4°C, and the time was 36-78 h. 3.根据权利要求1所述的检测氟虫腈及其代谢物的胶体金试纸条制备方法,其特征在于,所述金标抗体的制备具体为:3. the colloidal gold test strip preparation method that detects fipronil and its metabolites according to claim 1, is characterized in that, the preparation of described gold-labeled antibody is specifically: 取纯水加热沸腾,在搅拌条件下加入氯金酸溶液,再加入柠檬酸三钠溶液,得到胶体金溶液;Take pure water and heat to boil, add chloroauric acid solution under stirring condition, then add trisodium citrate solution to obtain colloidal gold solution; 取胶体金溶液,加入硼酸缓冲液,充分混匀之后逐滴加入所述单克隆抗体溶液反应,然后逐滴加入10% BSA封闭,得到混合溶液;Take the colloidal gold solution, add boric acid buffer solution, mix well, then add the monoclonal antibody solution drop by drop to react, then add 10% BSA drop by drop to block to obtain a mixed solution; 将所述混合溶液离心,弃去上清液,得到沉淀物,将所述沉淀物溶于重悬液中,得到金标抗体。The mixed solution is centrifuged, and the supernatant is discarded to obtain a precipitate, which is dissolved in the resuspension to obtain the gold-labeled antibody. 4.根据权利要求3所述的检测氟虫腈及其代谢物的胶体金试纸条制备方法,其特征在于,所述纯水、氯金酸溶液与柠檬酸三钠溶液的用量比500~900 mL:1~2mL:1~3 mL;4. the colloidal gold test strip preparation method that detects fipronil and its metabolites according to claim 3 is characterized in that, the consumption ratio of described pure water, chloroauric acid solution and trisodium citrate solution is 500~ 900 mL: 1~2mL: 1~3 mL; 所述胶体金溶液、单克隆抗体溶液、硼酸缓冲液和10%BSA用量比是3~6mL:18~48μg:300~600μL:200~800μL;Described colloidal gold solution, monoclonal antibody solution, boric acid buffer solution and 10%BSA dosage ratio are 3~6mL:18~48μg:300~600μL:200~800μL; 所述沉淀物和重悬液的用量比为0.1~1mg:300~500μL。The dosage ratio of the precipitate and the resuspension is 0.1-1 mg:300-500 μL. 5.根据权利要求1所述的检测氟虫腈及其代谢物的胶体金试纸条制备方法,其特征在于,所述胶体金试纸条的制备具体包括以下步骤:5. the colloidal gold test strip preparation method that detects fipronil and its metabolites according to claim 1, is characterized in that, the preparation of described colloidal gold test strip specifically comprises the following steps: 将样品垫放进含有0.2% Tween-20、1%蔗糖和1%BSA的0.01M pH 7.4 PBS溶液中浸泡后烘干;Soak the sample pad in a 0.01M pH 7.4 PBS solution containing 0.2% Tween-20, 1% sucrose and 1% BSA and then dry it; 将0.5~1 mg/mL包被原喷涂在硝酸纤维素膜上作为检测线,将0.2~0.6 mg / mL二抗喷涂在硝酸纤维素膜上作为质控线;Spray 0.5~1 mg/mL of the original coating on the nitrocellulose membrane as the detection line, and spray 0.2~0.6 mg/mL of the secondary antibody on the nitrocellulose membrane as the quality control line; 将所述样品垫、硝酸纤维素膜、吸水垫和底板进行组装。The sample pad, nitrocellulose membrane, absorbent pad and bottom plate were assembled. 6.一种检测氟虫腈及其代谢物的胶体金试纸条,其特征在于,根据权利要求1-5中任意一项所述检测氟虫腈及其代谢物的胶体金试纸条制备方法制备。6. A colloidal gold test strip for detecting fipronil and its metabolites, characterized in that, it is prepared according to the colloidal gold test strips for detecting fipronil and its metabolites described in any one of claims 1-5 Method preparation.
CN202010042620.7A 2020-01-15 2020-01-15 Colloidal gold test strip for detecting fipronil and its metabolites and preparation method thereof Active CN111187346B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010042620.7A CN111187346B (en) 2020-01-15 2020-01-15 Colloidal gold test strip for detecting fipronil and its metabolites and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010042620.7A CN111187346B (en) 2020-01-15 2020-01-15 Colloidal gold test strip for detecting fipronil and its metabolites and preparation method thereof

Publications (2)

Publication Number Publication Date
CN111187346A CN111187346A (en) 2020-05-22
CN111187346B true CN111187346B (en) 2023-05-05

Family

ID=70706313

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010042620.7A Active CN111187346B (en) 2020-01-15 2020-01-15 Colloidal gold test strip for detecting fipronil and its metabolites and preparation method thereof

Country Status (1)

Country Link
CN (1) CN111187346B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112147332B (en) * 2020-08-03 2023-10-10 江苏大学 A kind of colloidal gold immunochromatography test strip for rapid detection of endosulfan and its preparation and detection method
CN112834749B (en) * 2020-12-14 2023-05-02 黑龙江大学 Preparation method and application of test paper for detecting Cronobacter sakazakii
CN113049829A (en) * 2021-03-12 2021-06-29 河北省科学院生物研究所 Optical fiber probe and preparation method and application thereof
CN113025580B (en) * 2021-03-12 2022-08-16 河北省科学院生物研究所 Hybridoma cell strain, anti-fipronil monoclonal antibody produced by hybridoma cell strain and application of anti-fipronil monoclonal antibody
CN113636954B (en) * 2021-10-18 2021-12-31 天津国际生物医药联合研究院 Fipronil artificial antigen, preparation method and application
CN119246845B (en) * 2024-11-18 2025-04-18 南京林业大学 Pine wood nematode disease detection test strip and preparation method and application thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101100457A (en) * 2007-07-26 2008-01-09 浙江大学 Fipronil hapten compound, synthesis method and use thereof
CN107941785A (en) * 2018-01-03 2018-04-20 河南省农业科学院 A kind of surface-enhanced Raman gold label test strip for quickly detecting micro ethiprole and preparation method thereof
CN108226489A (en) * 2018-01-03 2018-06-29 河南省农业科学院 A kind of colloid gold label test strip for quickly detecting micro ethiprole and preparation method thereof
CN109696548A (en) * 2017-10-23 2019-04-30 北京维德维康生物技术有限公司 A kind of kit and its preparation method and application detecting Fipronil

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101100457A (en) * 2007-07-26 2008-01-09 浙江大学 Fipronil hapten compound, synthesis method and use thereof
CN109696548A (en) * 2017-10-23 2019-04-30 北京维德维康生物技术有限公司 A kind of kit and its preparation method and application detecting Fipronil
CN107941785A (en) * 2018-01-03 2018-04-20 河南省农业科学院 A kind of surface-enhanced Raman gold label test strip for quickly detecting micro ethiprole and preparation method thereof
CN108226489A (en) * 2018-01-03 2018-06-29 河南省农业科学院 A kind of colloid gold label test strip for quickly detecting micro ethiprole and preparation method thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Quantitative Detection of Fipronil and Fipronil-Sulfone in Sera of Black-Tailed Prairie Dogs and Rats after Oral Exposure to Fipronil by Camel Single-Domain Antibody-Based Immunoassays;Kai Wang 等;《Anal Chem》;20181221;第91卷(第2期);1532-1540 *
氟虫腈半抗原设计及抗体制备;董健等;《江苏农业学报》;20011030;第17卷(第03期);172-175 *
氟虫腈单克隆抗体制备及其性能分析;颜春荣等;《江苏农业学报》;20031030;第19卷(第03期);166-169 *

Also Published As

Publication number Publication date
CN111187346A (en) 2020-05-22

Similar Documents

Publication Publication Date Title
CN111187346B (en) Colloidal gold test strip for detecting fipronil and its metabolites and preparation method thereof
CN101261271B (en) Sudan red 1 immunity-chromatography test paper detection method
CN110441512B (en) Colloidal gold immunochromatography detection device for ethyl maltol hapten and ethyl maltol
CN108530373A (en) A kind of furans metabolite hapten, artificial antigen and its application in fluorescent quantitation immunochromatography
CN109265401B (en) Preparation method and application of iprodione hapten and antigen
CN109307761B (en) An indirect competitive ELISA method for the detection of furosine
CN101100456A (en) Fipronil artificial hapten and synthesis method, antigen and antibody and application
CN109897025B (en) Anticoagulant raticide hapten and artificial antigen as well as preparation method and application thereof
CN101100486A (en) Fipronil artificial antigen, antibody and use thereof
CN107271665B (en) Test strip for detecting salbutamol and application thereof
CN101407480A (en) Preparation of semicarbazide derivative hapten, antigen and antibody
CN110981875B (en) Atropine hapten, synthetic method thereof, antigen, antibody and application
CN110872344B (en) A kind of chloramphenicol complete antigen and its preparation method and application
CN103954749A (en) Fast immunological detection method for directly detecting furaltadone metablolite 3-amino-5-morpholinomethyl-2-oxazolidinone (AMOZ)
CN112067811A (en) Test strip for detecting alternaria alternata and application thereof
CN111978271A (en) Hexythiazole hapten and preparation method thereof, hexythiazole antigen, antibody and application thereof
CN111646959A (en) Dinotefuran hapten, colloidal gold labeled dinotefuran monoclonal antibody and dinotefuran colloidal gold detection device
Guo et al. Quantitative determination of prothioconazole in wheat grain, soybean, and pond water based on a polyclonal antibody
CN112147332B (en) A kind of colloidal gold immunochromatography test strip for rapid detection of endosulfan and its preparation and detection method
CN109265364A (en) A kind of preparation and application of pendimethalin haptens and antigen
CN108132348B (en) Sudan red III hapten, coupling antigen, antibody and colloidal gold rapid detection device and application thereof
CN109942624B (en) Glufosinate hapten, artificial antigen, antibody, preparation method and detection device thereof
CN113831253A (en) A kind of pendimethalin hapten and its preparation method and application
CN109856091B (en) A time-resolved fluorescent test strip for detecting monocrotophos and its application
CN110927383A (en) A kind of fluorescent microsphere immunochromatographic test strip for detection of olaquindox residue and its application

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
CB03 Change of inventor or designer information

Inventor after: Zhou Xinghua

Inventor after: Zhang Caiqin

Inventor after: Zhang Xun

Inventor after: Zhang Tao

Inventor after: Xiao Xiang

Inventor after: Wang Yun

Inventor before: Zhou Xinghua

Inventor before: Zhang Caiqin

Inventor before: Zhang Xun

Inventor before: Xiao Xiang

Inventor before: Wang Yun

CB03 Change of inventor or designer information
GR01 Patent grant
GR01 Patent grant